Retroperitoneal Sarcoma — Trials

Retroperitoneal Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02587169	Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum(GEIS-27)	unknown	Phase 1 / Phase 2	40	Broto, Javier Martín, M.D.INDIV	1	Oct 27, 2015	clinicaltrials

Data updated 22 days agoSource updated Oct 27, 2015source: clinicaltrials